Clinical Pharmacology and Therapeutics - Table of Contents alert Volume 96 Issue 5

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 96, Issue 5 (November 2014) In this issue In This Issue Editorial News & Views Perspectives Discovery & Development Clinical Trial State of the Art Research Corrigendum Erratum Also new AOP Sign up for CPT: Pharmacometrics & Systems Pharmacology e-alerts Sign up for e-alerts Recommend to your library Web feed Subscribe In This Issue Top In This Issue Clin Pharmacol Ther 2014 96: 517; 10.1038/clpt.2014.181 Full Text Editorial Top Drug Development (and Academic Medicine): Charting the Course Forward R J Hohl Clin Pharmacol Ther 2014 96: 519-522; 10.1038/clpt.2014.171 Abstract | Full Text News & Views Top HIGHLIGHTS Clin Pharmacol Ther 2014 96: 524-525; 10.1038/clpt.2014.180 Full Text ASCPT NEWS Clin Pharmacol Ther 2014 96: 526-530; 10.1038/clpt.2014.172 Full Text Perspectives Top OPINION The Prescribing Performance and Confidence of Final-Year Medical Students D J Brinkman, J Tichelaar, M A van Agtmael, R Schotsman, Th P G M de Vries and M C Richir Clin Pharmacol Ther 2014 96: 531-533; 10.1038/clpt.2014.162 Abstract | Full Text COMMENTARY Looking for Virtuous Promiscuity: Electrocardiographic Evidence of Multichannel Drug Block M C Haigney Clin Pharmacol Ther 2014 96: 534-536; 10.1038/clpt.2014.165 Abstract | Full Text Application of Systems Pharmacology to Explore Mechanisms of Hepatotoxicity J Shon and D R Abernethy Clin Pharmacol Ther 2014 96: 536-537; 10.1038/clpt.2014.167 Abstract | Full Text Discovery & Development Top DISCOVERY The Evolving Tale of Immunomodulatory Drugs and Cereblon S A Holstein Clin Pharmacol Ther 2014 96: 538-541; advance online publication, August 21, 2014; 10.1038/clpt.2014.168 Abstract | Full Text CPIC GUIDELINES Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing K E Caudle, A E Rettie, M Whirl-Carrillo, L H Smith, S Mintzer, M T M Lee, T E Klein and J T Callaghan Clin Pharmacol Ther 2014 96: 542-548; advance online publication, August 6, 2014; 10.1038/clpt.2014.159 Abstract | Full Text Clinical Trial Top Differentiating Drug-Induced Multichannel Block on the Electrocardiogram: Randomized Study of Dofetilide, Quinidine, Ranolazine, and Verapamil L Johannesen, J Vicente, J W Mason, C Sanabria, K Waite-Labott, M Hong, P Guo, J Lin, J S Sørensen, L Galeotti, J Florian, M Ugander, N Stockbridge and D G Strauss Clin Pharmacol Ther 2014 96: 549-558; advance online publication, July 23, 2014; 10.1038/clpt.2014.155 Abstract | Full Text State of the Art Top Accelerated Access to Innovative Medicines for Patients in Need OPEN L G Baird, R Banken, H-G Eichler, F B Kristensen, D K Lee, J C W Lim, R Lim, C Longson, E Pezalla, T Salmonson, D Samaha, S Tunis, J Woodcock and G Hirsch Clin Pharmacol Ther 2014 96: 559-571; advance online publication, July 9, 2014; 10.1038/clpt.2014.145 Abstract | Full Text Research Top REVIEW Optimizing Dosing of Oncology Drugs L Minasian, O Rosen, D Auclair, A Rahman, R Pazdur and R L Schilsky Clin Pharmacol Ther 2014 96: 572-579; advance online publication, August 8, 2014; 10.1038/clpt.2014.153 Abstract | Full Text ARTICLES Adjusted Indirect Treatment Comparison of the Bioavailability of WHO-Prequalified First-Line Generic Antituberculosis Medicines L Gwaza, J Gordon, J Welink, H Potthast, H Leufkens, M Stahl and A García-Arieta Clin Pharmacol Ther 2014 96: 580-588; advance online publication, July 2, 2014; 10.1038/clpt.2014.144 Abstract | Full Text Systems Pharmacology Modeling Predicts Delayed Presentation and Species Differences in Bile Acid–Mediated Troglitazone Hepatotoxicity K Yang, J L Woodhead, P B Watkins, B A Howell and K L R Brouwer Clin Pharmacol Ther 2014 96: 589-598; advance online publication, July 28, 2014; 10.1038/clpt.2014.158 Abstract | Full Text A Pharmacokinetic–Viral Kinetic Model Describes the Effect of Alisporivir as Monotherapy or in Combination With Peg-IFN on Hepatitis C Virologic Response T H T Nguyen, F Mentré, M Levi, J Yu and J Guedj Clin Pharmacol Ther 2014 96: 599-608; advance online publication, August 28, 2014; 10.1038/clpt.2014.173 Abstract | Full Text Inflammation-Related Genetic Variants Predict Toxicity Following Definitive Radiotherapy for Lung Cancer X Pu, L Wang, J Y Chang, M A T Hildebrandt, Y Ye, C Lu, H D Skinner, N Niu, G D Jenkins, R Komaki, J D Minna, J A Roth, R M Weinshilboum and X Wu Clin Pharmacol Ther 2014 96: 609-615; advance online publication, July 23, 2014; 10.1038/clpt.2014.154 Abstract | Full Text Inconsistencies and Misleading Information in Officially Approved Prescribing Information From Three Major Drug Markets B Pfistermeister, A Saß, M Criegee-Rieck, T Bürkle, M F Fromm and R Maas Clin Pharmacol Ther 2014 96: 616-624; advance online publication, July 25, 2014; 10.1038/clpt.2014.156 Abstract | Full Text Corrigendum Top CORRIGENDUM: Identification and Characterization of a Defective CYP3A4 Genotype in a Kidney Transplant Patient With Severely Diminished Tacrolimus Clearance Clin Pharmacol Ther 2014 96: 625; 10.1038/clpt.2014.151 Full Text CORRIGENDUM: Genetic Variations in GRIA1 on Chromosome 5q33 Related to Asparaginase Hypersensitivity Clin Pharmacol Ther 2014 96: 625; 10.1038/clpt.2014.152 Full Text Erratum Top ERRATUM: Genetic Variants in Transcription Factors Are Associated With the Pharmacokinetics and Pharmacodynamics of Metformin Clin Pharmacol Ther 2014 96: 626; 10.1038/clpt.2014.182 Full Text Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Clinical Pharmacology & Therapeutics. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.